Tailoring Biopharma Development to Your Needs

“FyoniBios’ versatile cell line platforms and expertise in glycobiology were instrumental in testing our complex product candidates. Their support enabled us to make informed decisions with confidence. Highly recommended!”

“We’ve been highly impressed with FyoniBio’s cell line and process development services. The team consistently delivers quality results on time, with excellent communication making the process seamless and efficient.”

“Working with FyoniBio’s Clinical Bioanalysis group to develop and validate an ADA assay for Eleva was an exceptionally positive experience. When the standard approach proved ineffective, their expertise and innovative thinking led to a new assay format that met our requirements and guidelines. Their dedication and high-quality results were evident throughout. We’re highly satisfied and look forward to the clinical sample analysis phase.”

“FyoniBio has been a solid and trustworthy partner in mass spectrometry-based analytics. Over the course of several years, the company has established a method for quantifying short-chain fatty acids in cell culture supernatants using ultra-performance liquid chromatography–mass spectrometry. Working with FyoniBio has been a real advantage, and we look forward to more successful projects together. “

“It is a real pleasure to work with the analytical team at FyoniBio! Always in time and even with more complicated Mass Spec analysis the results are displayed and explained in an easy to understand way even for complicated things. Absolutely worth it!”